229 related articles for article (PubMed ID: 29665865)
1. Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
Li T; Liu Q; Garza N; Kornblau S; Jin VX
Genome Med; 2018 Apr; 10(1):30. PubMed ID: 29665865
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis reveals a correlation of exon-skipping events with splicing, transcription and epigenetic factors.
Ye Z; Chen Z; Lan X; Hara S; Sunkel B; Huang TH; Elnitski L; Wang Q; Jin VX
Nucleic Acids Res; 2014 Mar; 42(5):2856-69. PubMed ID: 24369421
[TBL] [Abstract][Full Text] [Related]
3. Mitotic accumulation of dimethylated lysine 79 of histone H3 is important for maintaining genome integrity during mitosis in human cells.
Guppy BJ; McManus KJ
Genetics; 2015 Feb; 199(2):423-33. PubMed ID: 25533199
[TBL] [Abstract][Full Text] [Related]
4. DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation.
Godfrey L; Crump NT; Thorne R; Lau IJ; Repapi E; Dimou D; Smith AL; Harman JR; Telenius JM; Oudelaar AM; Downes DJ; Vyas P; Hughes JR; Milne TA
Nat Commun; 2019 Jun; 10(1):2803. PubMed ID: 31243293
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
Li XW; Shi BY; Yang QL; Wu J; Wu HM; Wang YF; Wu ZJ; Fan YM; Wang YP
BMC Cancer; 2015 Dec; 15():954. PubMed ID: 26674321
[TBL] [Abstract][Full Text] [Related]
6. Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages.
Chen X; Liu X; Zhang Y; Huai W; Zhou Q; Xu S; Chen X; Li N; Cao X
Cell Mol Immunol; 2020 Jan; 17(1):76-84. PubMed ID: 30275539
[TBL] [Abstract][Full Text] [Related]
7. DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions.
Ho LL; Sinha A; Verzi M; Bernt KM; Armstrong SA; Shivdasani RA
Mol Cell Biol; 2013 May; 33(9):1735-45. PubMed ID: 23428873
[TBL] [Abstract][Full Text] [Related]
8. TALE-directed local modulation of H3K9 methylation shapes exon recognition.
Bieberstein NI; Kozáková E; Huranová M; Thakur PK; Krchňáková Z; Krausová M; Carrillo Oesterreich F; Staněk D
Sci Rep; 2016 Jul; 6():29961. PubMed ID: 27439481
[TBL] [Abstract][Full Text] [Related]
9. DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation.
Cattaneo P; Kunderfranco P; Greco C; Guffanti A; Stirparo GG; Rusconi F; Rizzi R; Di Pasquale E; Locatelli SL; Latronico MV; Bearzi C; Papait R; Condorelli G
Cell Death Differ; 2016 Apr; 23(4):555-64. PubMed ID: 25526092
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nucleosome positioning and progesterone-induced alternative splicing in breast cancer cells.
Iannone C; Pohl A; Papasaikas P; Soronellas D; Vicent GP; Beato M; ValcáRcel J
RNA; 2015 Mar; 21(3):360-74. PubMed ID: 25589247
[TBL] [Abstract][Full Text] [Related]
11. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
[TBL] [Abstract][Full Text] [Related]
12. Effects of RNAi-mediated knockdown of histone methyltransferases on the sex-specific mRNA expression of Imp in the silkworm Bombyx mori.
Suzuki MG; Ito H; Aoki F
Int J Mol Sci; 2014 Apr; 15(4):6772-96. PubMed ID: 24758924
[TBL] [Abstract][Full Text] [Related]
13. Splicing-associated chromatin signatures: a combinatorial and position-dependent role for histone marks in splicing definition.
Agirre E; Oldfield AJ; Bellora N; Segelle A; Luco RF
Nat Commun; 2021 Jan; 12(1):682. PubMed ID: 33514745
[TBL] [Abstract][Full Text] [Related]
14. Histone modifications are associated with transcript isoform diversity in normal and cancer cells.
Podlaha O; De S; Gonen M; Michor F
PLoS Comput Biol; 2014 Jun; 10(6):e1003611. PubMed ID: 24901363
[TBL] [Abstract][Full Text] [Related]
15. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
16. A chromatin code for alternative splicing involving a putative association between CTCF and HP1α proteins.
Agirre E; Bellora N; Alló M; Pagès A; Bertucci P; Kornblihtt AR; Eyras E
BMC Biol; 2015 May; 13():31. PubMed ID: 25934638
[TBL] [Abstract][Full Text] [Related]
17. Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Wang J; Ye Z; Huang TH; Shi H; Jin VX
Methods Mol Biol; 2017; 1513():163-170. PubMed ID: 27807836
[TBL] [Abstract][Full Text] [Related]
18. CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells.
Xia H; Chen D; Wu Q; Wu G; Zhou Y; Zhang Y; Zhang L
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):911-921. PubMed ID: 28733224
[TBL] [Abstract][Full Text] [Related]
19. Histone modifications involved in cassette exon inclusions: a quantitative and interpretable analysis.
Liu H; Jin T; Guan J; Zhou S
BMC Genomics; 2014 Dec; 15(1):1148. PubMed ID: 25526687
[TBL] [Abstract][Full Text] [Related]
20. The chromatin remodeler ZmCHB101 impacts alternative splicing contexts in response to osmotic stress.
Yu X; Meng X; Liu Y; Wang X; Wang TJ; Zhang A; Li N; Qi X; Liu B; Xu ZY
Plant Cell Rep; 2019 Feb; 38(2):131-145. PubMed ID: 30443733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
